Transthyretin-associated neuropathic amyloidosis: Pathogenesis and treatment

Neurology

Volumn 56, Issue 4, 2001, Pages 431-435

  Hund, E ^a   Linke, R P ^b   Willig, F ^c   Grau, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c Academic Hospital for Internal Medicine Speyererhof   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

AMYLOIDOSIS; AUTONOMIC DYSFUNCTION; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CARPAL TUNNEL SYNDROME; COMORBIDITY; CORNEA DISEASE; CRANIAL NEUROPATHY; EXTRACELLULAR MATRIX; GASTROINTESTINAL DISEASE; GENE MUTATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LIVER TRANSPLANTATION; NEUROPATHY; ONSET AGE; PHENOTYPE; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; STOMACH ULCER; TREATMENT INDICATION; TREATMENT OUTCOME; VITREOUS OPACITY;

EID: 0035957104     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.4.431     Document Type: Review

References (56)

1. The genetics of the amyloidoses
2. Amyloidosis
3. Peripheral nerve amyloidosis
4. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy
5. Ocular amyloidosis
6. Clinical and pathohistological ocular findings in a patient with familial amyloid polyneuropathy of the Portuguese type
7. A European family with histidine 58 transthyretin mutation in familial amyloid polyneuropathy
8. Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant
9. Familial amyloidotic polyneuropathy with late-onset and well-preserved autonomic function: A Japanese kindred with novel mutant transthyretin (Ala97 to Gly)
10. Familial amyloid polyneuropathy: New developments in genetics and treatment
11. Amyloid neuropathy simulating lower motor neuron disease
12. Transthyretin Ile20, a new variant associated with late-onset cardiac amyloidosis
13. A novel variant of transthyretin, 59Thr→Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family
14. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans
15. A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis
16. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells
17. Leptomeningeal amyloid and variant transthyretins
18. Transthyretin amyloidosis: A new mutation associated with dementia
19. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)
20. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis
21. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene
22. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64
23. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal)
24. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy
25. Familial amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset, and prevalence
26. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions
27. Anticipation in early - But not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan
28. Transthyretin Tyr77 familial amyloid polyneuropathy: A clinicopathological study of a large kindred
29. Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: A clinical, genetic, and epidemiological study
30. Familial amyloid polyneuropathy in Taiwan: Identification of transthyretin variant (Leu55→Pro)
31. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54
32. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected
33. New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy
34. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
35. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M
36. FAP mutations destabilize transthyretin facilitating conformational changes required for amyloid formation
37. Designing conditions for in vitro formation of amyloid protofilaments and fibrils
38. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis
39. Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type
40. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: Regression of visceral amyloid following liver transplantation
41. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series
42. Screening and biochemical characterization of transthyretin variants in the Portuguese population
43. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing
44. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP)
45. Liver transplantation for hereditary, transthyretin amyloidosis
46. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy
47. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
48. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I
49. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
50. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis
51. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis
52. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant
53. Orthotopic liver transplantation for familial amyloidotic polyneuropathy: A pathological study
54. Potential treatment of transthyretin-type amyloidoses by sulfite
55. 4′-Iodo-4′-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid
56. Rational design of potent human transthyretin amyloid disease inhibitors